Your browser doesn't support javascript.
loading
The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness.
Thomas, Geethu Emily; Egan, Grace; García-Prat, Laura; Botham, Aaron; Voisin, Veronique; Patel, Parasvi S; Hoff, Fieke W; Chin, Jordan; Nachmias, Boaz; Kaufmann, Kerstin B; Khan, Dilshad H; Hurren, Rose; Wang, Xiaoming; Gronda, Marcela; MacLean, Neil; O'Brien, Cristiana; Singh, Rashim P; Jones, Courtney L; Harding, Shane M; Raught, Brian; Arruda, Andrea; Minden, Mark D; Bader, Gary D; Hakem, Razq; Kornblau, Steve; Dick, John E; Schimmer, Aaron D.
Afiliação
  • Thomas GE; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Egan G; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • García-Prat L; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Botham A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Voisin V; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Patel PS; Terrence Donnelly Centre for Cellular and Biomedical Research, University of Toronto, Toronto, Ontario, Canada.
  • Hoff FW; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Chin J; Department of Pediatric Hematology/Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Nachmias B; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Kaufmann KB; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Khan DH; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Hurren R; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Wang X; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Gronda M; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • MacLean N; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • O'Brien C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Singh RP; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Jones CL; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Harding SM; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Raught B; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Arruda A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Minden MD; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Bader GD; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Hakem R; Terrence Donnelly Centre for Cellular and Biomedical Research, University of Toronto, Toronto, Ontario, Canada.
  • Kornblau S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Dick JE; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Schimmer AD; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Nat Cell Biol ; 24(6): 872-884, 2022 06.
Article em En | MEDLINE | ID: mdl-35668135
ABSTRACT
Mitochondrial metabolites regulate leukaemic and normal stem cells by affecting epigenetic marks. How mitochondrial enzymes localize to the nucleus to control stem cell function is less understood. We discovered that the mitochondrial metabolic enzyme hexokinase 2 (HK2) localizes to the nucleus in leukaemic and normal haematopoietic stem cells. Overexpression of nuclear HK2 increases leukaemic stem cell properties and decreases differentiation, whereas selective nuclear HK2 knockdown promotes differentiation and decreases stem cell function. Nuclear HK2 localization is phosphorylation-dependent, requires active import and export, and regulates differentiation independently of its enzymatic activity. HK2 interacts with nuclear proteins regulating chromatin openness, increasing chromatin accessibilities at leukaemic stem cell-positive signature and DNA-repair sites. Nuclear HK2 overexpression decreases double-strand breaks and confers chemoresistance, which may contribute to the mechanism by which leukaemic stem cells resist DNA-damaging agents. Thus, we describe a non-canonical mechanism by which mitochondrial enzymes influence stem cell function independently of their metabolic function.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Hexoquinase Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Hexoquinase Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article